Activity of tepotinib in hepatocellular carcinoma (HCC) with high-level MET amplification (METamp): Preclinical and clinical evidence.

Affiliation auteurs!!!! Error affiliation !!!!
TitreActivity of tepotinib in hepatocellular carcinoma (HCC) with high-level MET amplification (METamp): Preclinical and clinical evidence.
Type de publicationJournal Article
Year of Publication2021
AuteursFaivre SJ, Blanc J-F, Pan H, Grando V, Lim HYeong, Gracian ACubillo, Isambert N, Johne A, Schumacher K, Stroh C, Friese-Hamim M, O'Brate A, Zhou D, Qin S
JournalJOURNAL OF CLINICAL ONCOLOGY
Volume39
Date PublishedJAN 20
Type of ArticleMeeting Abstract
ISSN0732-183X
DOI10.1200/JCO.2021.39.3_suppl.329